- Home
- SABS vs NVNI Comparison
SABS vs NVNI Comparison
Compare SABS & NVNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- NVNI
- Stock Information
- Founded
- SABS 2014
- NVNI 2019
- Country
- SABS United States
- NVNI Brazil
- Employees
- SABS N/A
- NVNI N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- NVNI
- Sector
- SABS Health Care
- NVNI
- Exchange
- SABS Nasdaq
- NVNI Nasdaq
- Market Cap
- SABS 15.8M
- NVNI 14.3M
- IPO Year
- SABS N/A
- NVNI N/A
- Fundamental
- Price
- SABS $1.85
- NVNI $0.40
- Analyst Decision
- SABS Strong Buy
- NVNI
- Analyst Count
- SABS 6
- NVNI 0
- Target Price
- SABS $11.17
- NVNI N/A
- AVG Volume (30 Days)
- SABS 58.6K
- NVNI 57.8M
- Earning Date
- SABS 05-27-2025
- NVNI 05-27-2025
- Dividend Yield
- SABS N/A
- NVNI N/A
- EPS Growth
- SABS N/A
- NVNI N/A
- EPS
- SABS N/A
- NVNI N/A
- Revenue
- SABS $377,835.00
- NVNI $23,558,620.00
- Revenue This Year
- SABS N/A
- NVNI $25.91
- Revenue Next Year
- SABS $50.00
- NVNI $21.68
- P/E Ratio
- SABS N/A
- NVNI N/A
- Revenue Growth
- SABS N/A
- NVNI 38.59
- 52 Week Low
- SABS $1.00
- NVNI $0.14
- 52 Week High
- SABS $5.01
- NVNI $12.19
- Technical
- Relative Strength Index (RSI)
- SABS 58.32
- NVNI 50.54
- Support Level
- SABS $1.76
- NVNI $0.37
- Resistance Level
- SABS $2.15
- NVNI $0.51
- Average True Range (ATR)
- SABS 0.19
- NVNI 0.15
- MACD
- SABS 0.02
- NVNI 0.02
- Stochastic Oscillator
- SABS 51.61
- NVNI 40.08
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About NVNI Nvni Group Limited
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.